Storyline

Price Transparency

Rules requiring insurers and providers to disclose prices, and whether disclosure changes what patients pay.

Background from our research

Timeline

Developments, newest first

Final rule

Federal agencies finalize insurer price-transparency overhaul

Issued Oct 5, 2026; prescription drug file schema Dec 2027

From Briefing for the week of September 30 – October 7, 2026

What changed

CMS, Labor, and Treasury finalized revised Transparency in Coverage rules. They require quarterly reporting and executive certification of accuracy, lower the out-of-network reporting threshold from 20 to 11 claims, and set a new prescription drug file schema for December 2027. The agencies estimate about $175 million in annual savings and about $400 million in one-time costs.

Why it matters

Disclosure only helps patients if the data is accurate and usable. Certification and quarterly updates address accuracy, but the estimated savings are small relative to national spending.

  • Accountability
  • Affordability

Sources

Background from our research

Storylines

← All Weekly Briefings